Skip to content

A randomized placebo-controlled clinical trial to evaluate the efficacy of the standardized homoeopathic remedy Gelsemium sempervirens versus placebo in reducing performance anxiety among junior college students assessed using the Academic Anxiety Scale.

A randomized placebo-controlled clinical trial on the efficacy of a standardized homeopathic remedy Gelsemium sempervirens in the management of performance anxiety disorders among junior college student - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095119
Enrollment
52
Registered
2025-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F418- Other specified anxiety disorders

Interventions

Intervention1: Gelsemium sempervirens: Standardized homeopathic remedy Gelsemium sempervirens is administered orally in the required potency (30C to 1M) in the centesimal scale as per homeopathic poso

Sponsors

Dr Shaina Bronika James
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Junior college students aged 15 to 20 years of both genders. 2. Academic Anxiety Scale (AAS) score greater than 11. 3. Not receiving any other form of treatment for anxiety disorder. 4. Willing to participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Students with severe psychiatric illnesses, including major depressive disorder, bipolar disorder, psychotic disorder and schizophrenia. 2. Currently using any psychiatric medication.

Design outcomes

Primary

MeasureTime frame
Reduction in performance anxiety symptoms measured by Academic Anxiety Scale (AAS) scores.Timepoint: Assessment will be done at baseline and at the end of 6 months using the Academic Anxiety Scale.

Secondary

MeasureTime frame
Change in anxiety scores (Academic Anxiety Scale) comparison between intervention & placebo groups over the study period.Timepoint: Assessment will be done at baseline & at the end of 6 months using the Academic Anxiety Scale.

Countries

India

Contacts

Public ContactDr Poonam P Rathi

Bharati Vidyapeeth (Deemed to be a University), Homoeopathic medical college and Hospital

poonam.rathi@bharatividyapeeth.edu9665745589

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026